Clinical trial
Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma
NCT03270722 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma
- Lead sponsor
- Stanford University
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- January 1, 2018
- Completion date
- May 31, 2020
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dysphagia, gerd - gastro-esophageal reflux disease, scleroderma